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ABSTRACT. Hepatitis E virus (HEV) is known to cause zoonotic infections from pigs, wild boars 
and deer. Domestic pigs have been used as an experimental animal model in medical research 
and training; however, the risks of HEV infection from pigs during animal experiments are largely 
unknown. Here, we retrospectively investigated the seroprevalence and detection rates of viral 
RNA in 73 domestic pigs (average 34.5 kg) introduced into an animal experimental facility in a 
medical school during 2012–2016. We detected anti-HEV immunoglobulin G antibodies in 24 
of 73 plasma samples (32.9%), though none of the samples were positive for viral RNA. Plasma 
samples of 18 pigs were sequentially monitored and were classified into four patterns: sustained 
positive (5 pigs), sustained negative (5 pigs), conversion to positive (6 pigs) and conversion 
to negative (2 pigs). HEV genomes were detected in 2 of 4 liver samples from pigs that were 
transported from the same farm during 2016–2017. Two viral sequences of the overlapping open 
reading frame (ORF) 2/3 region (97 bp) were identical and phylogenetically fell into genotype 
3. A 459-bp length of the ORF2 region of an amplified fragment from a pig transported in 2017 
was clustered with the wbJYG1 isolate (subgenotype 3b) with 91.5% (420/459 bp) nucleotide 
identity. Based on our results, we suggest that domestic pigs introduced into animal facilities carry 
a potential risk of HEV infection to researchers, trainees and facility staff. Continuous surveillance 
and precautions are important to prevent HEV infection in animal facilities.
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The use of pigs as an experimental animal model in medical research and training has expanded over the past several decades, 
because the anatomical and physiological properties of pigs are similar to those of humans [6]. Several types of pigs, i.e., domestic 
pigs, miniature pigs and micromini pigs, are available for medical research. Among them, domestic pigs are most commonly 
used due to their cost-effectiveness. However, use of domestic pigs carries a potential risk of exposing the researchers to zoonotic 
infectious diseases, since the animals are not kept under specific-pathogen-free (SPF) conditions. Miniature pigs and micromini 
pigs are easier to handle and more suitable for research, but the production of these pigs for animal experiments is limited and they 
are more expensive.
Hepatitis E is a notable zoonotic disease in swine industries [10]. Hepatitis E virus (HEV) is a causative agent which is 
transmitted from pigs and likely other animal species (e.g., wild boar and deer) that are known as viral reservoirs. HEV is 
a non-enveloped, positive-sense RNA virus with a genome of approximately 7.2 kb in length and is a member of the genus 
Orthohepevirus in the family Hepeviridae [18]. Orthohepevirus consists of four species, Orthohepevirus A to D. It is recognized 
that four genotypes (HEV-1 to -4) within species Orthohepevirus A infect humans and that the HEV-3 and HEV-4 cause zoonotic 
diseases. Recent studies revealed that HEV-7 and Orthohepevirus C, known as rat HEV, also infected to humans by liver 
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transplantation [7, 20].
Anti-HEV immunoglobulin G (IgG) antibodies were detected in 58% of the serum samples from pigs aged 2 to 6 months at 
25 commercial farms in Japan, and viral RNAs were also detected in 10% of the tested samples [21]. Interestingly, all the HEV 
RNA-positive samples were collected from 3- to 4-month-old pigs. In previous reports, swine HEV RNA has also been detected 
in various tissues during the viremia period, as well as for a remarkably long period of time in the feces [5, 25]. Therefore, pig 
handlers such as swine veterinarians and pig farmers who are in contact with pigs have high risk of infection, as evidenced by 
previous reports worldwide [2, 13, 26]. Accordingly, medical researchers and trainees using domestic pigs and staff rearing them in 
the animal experimental facilities might also be under a high risk of infection.
In the present study, we performed a serological survey retrospectively to detect HEV-specific IgG antibodies as well as 
a molecular detection assay in domestic pigs introduced into an experimental animal facility in Okayama University from a 
commercial pig farm in order to assess HEV infection risk in the facility.
MATERIALS AND METHODS
Pigs
Seventy-three domestic pigs at a farrow-to-finish farm (where pigs are bred and raised to their slaughter weight) located 
in Okayama prefecture, 3 domestic pigs guaranteed HEV-free for safe animal experiments (Zen-noh Premium Pigs: Zen-noh 
Livestock, Tokyo, Japan) and 3 SPF-miniature pigs aged 18 months (Göttingen Minipigs: Oriental Yeast, Tokyo, Japan) were 
introduced into the Department of Animal Resources, Advanced Science Research Center, Okayama University over the years 
2012 to 2016 for animal experiments. All of these animal experiments were approved by the Animal Care and Use Committee 
of Okayama University. The numbers of domestic pigs introduced each year were as follows: 36 including 3 SPF-miniature 
pigs in 2012, 9 in 2013, 14 including 3 Zen-noh Premium Pigs in 2014, 6 in 2015 and 14 in 2016. The mean body weight of 
the 73 domestic pigs and 3 Zen-noh Premium Pigs at the time of the first animal experiment was 34.5 kg (25.0–73.0 kg), which 
corresponds to an age of approximately 80–90 days in domestic pigs. Furthermore, 4 domestic pigs whose body weight and 
estimated age were same as the above-mentioned, were transported from the same farm during 2016 to 2017 (2016: n=2; 2017: 
n=2). However, only liver samples were available for this study in these pigs, since this study was conducted by sample sharing 
from another medical research using domestic pigs.
Samples
Plasma samples were collected at the first animal experiment after an acclimation period (more than 4–5 days) and stored at 
−80°C before use. Sequential blood samples were also collected in 18 of the 73 domestic pigs. Six plasma samples collected from 
3 Zen-noh Premium Pigs and 3 SPF-miniature pigs were used as a negative control in this study. Liver samples were collected 
from 4 domestic pigs transported from the same farm (2016: n=2; 2017: n=2).
Enzyme-linked immunosorbent assay (ELISA)
Anti-HEV IgG antibody was screened using a PrioCHECK HEV Ab porcine ELISA kit (Mikrogen, Neuried, Germany) 
according to the manufacturer’s instructions. The optical density (OD) at 450 nm was measured using a Flex Station 3 (Molecular 
Devices, Sunnyvale, CA, U.S.A.). Samples with OD values above or at the cut-off, which was calculated in each 96-well plate 
according to the manufacturer’s instructions, were considered positive.
Nested reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was extracted from 140 µl of swine plasma or 10% (w/v) liver homogenates with a QIAamp Viral RNA Mini Kit 
(Qiagen, Hilden, Germany) according to the manufacturer’s instructions. Two nested RT-PCR assays for genotypes 1–4 were 
performed as described elsewhere [4, 15]. RT-PCR (ORF2/3-137PCR) developed by Inoue et al. [4] was used for screening 
of plasma and liver samples; the sensitivity of this screening in our laboratory was 1 copy using pCAGGS-HEVcap(1-660) 
constructed from the genotype 4 strain JTF-Yamagu11 [28] as a template. Another RT-PCR (ORF2-457PCR) with a sensitivity of 
1,000 copies was used for only liver samples.
Sequence analysis
PCR-positive products were purified using a FastGene Gel/PCR Extraction Kit (Nippon Genetics, Tokyo, Japan) and then 
subjected to direct sequencing using a BigDye Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific, Waltham, MA, 
U.S.A.), and a 3130 Genetic Analyzer (Applied Biosystems, Foster City, CA, U.S.A.); all these procedures were carried out 
according to the manufacturer’s instructions. The sequence data were aligned using Clustal W software, and then neighbor-joining 
phylogenetic trees were generated with 1,000 bootstrap replications using MEGA 6.0 software [23].
RESULTS
Anti-HEV IgG antibodies were detected by ELISA in 24 of 73 specimens (32.9%) of domestic pigs introduced from the farm 
(Fig. 1A). Six samples derived from 3 Zen-noh Premium Pigs and 3 SPF-miniature pigs were all negative. The annual prevalences 
of anti-HEV IgG antibodies in domestic pigs introduced from the farm were 48.5% (16/33) in 2012, 44.4% (4/9) in 2013, 18.2% 
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Fig. 1. Anti-hepatitis E virus (HEV)-specific immunoglobulin G (IgG) antibodies detected in the plasma samples collected from introduced pigs 
at the first animal experiment after the acclimation period (A) and 18 kinetics of anti-HEV IgG in the introduced domestic pigs (B). (A) The Y 
axis indicates the optical density (OD) values. The X axis indicates the sample identification numbers (#1 to 73: domestic pigs were numbered 
in ascending order based on the time of their introduction, and color-coded by introduction year). The negative control indicates the samples 
collected from 3 SPF-miniature pigs in 2012 (#74–76) and 3 Zen-noh Premium Pigs in 2014 (#77–79). (B) The sample identification numbers are 
shown at the top of the figure. The Y axis indicates the OD values. The X axis indicates the days post-first animal experiment (day 0: first ELISA 
detection as shown in Fig. 1A). Red and black dots indicate positive and negative values, respectively. Patterns A–D represents a sustained 
positive pattern, sustained negative pattern, seroconversion pattern, and conversion from positive to negative pattern, respectively.
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(2/11) in 2014, 0% (0/6) in 2015 and 14.3% (2/14) in 2016.
The kinetics of the OD values in 18 sequential plasma samples of domestic pigs were classified into 4 patterns: pattern A 
represents sustained positives, pattern B represents sustained negatives, pattern C exhibits seroconversion, pattern D exhibits 
conversion from positive to negative. There were 5 pigs (#20, #35, #37, #47 and #65) showing pattern A (sustained positives), 5 
pigs (#19, #30, #63, #64 and #70) showing pattern B (sustained negatives), 6 pigs (#5, #6, #11, #13, #14 and #22) showing pattern 
C (seroconversion) and 2 pigs (#1 and #26) showing pattern D (conversion to negative) (Fig. 1B).
Viral RNA was not detected in plasma samples collected at the first animal experiment by ORF2/3-137PCR, despite the fact that 
this RT-PCR was capable of detecting 1 copy of cDNA. Next, we tried to detect HEV in 4 liver samples collected in 2016 (n=2) 
and 2017 (n=2) by both ORF2/3-137PCR and ORF2-457PCR. Viral RNA was detected in a sample in 2016 (swHEV-OKYM/16-2) 
by only ORF2/3-137PCR and in a sample in 2017 (swHEV-OKYM/17-1) by both ORF2/3-137PCR and ORF2-457PCR. The 
sequences of the above RT-PCR products were deposited to DDBJ and assigned to accession numbers LC422839, LC422840 and 
LC422841. Phylogenetic analysis revealed that the amplified sequences fell into genotype 3 (Fig. 2). The two fragments (swHEV-
OKYM/16-2 and swHEV-OKYM/17-1) revealed by ORF2/3-137PCR (Fig. 2a) were closely related with 97.9% nucleotide 
identity (95/97 bp) to the swJ570 isolate that was identified in swine serum in Tochigi Prefecture [17]. The sequences of swHEV-
OKYM/16-2 and swHEV-OKYM/17-1 were identical, indicating that the same or similar genotype 3 strains were circulating in 
this farm in the years 2016 and 2017. The sequence of the ORF2-457PCR fragment in swHEV-OKYM/17-1 was clustered with the 
wbJYG1 isolate, which was identified from wild boar in Yamaguchi Prefecture in 2005 [16], with 91.5% (420/459 bp) nucleotide 
identity (Fig. 2b). On the other hand, swHEV-OKYM/17-1 showed 88.7% (407/459 bp) nucleotide identity to the swJ570 isolate in 
this sequence region.
DISCUSSION
Domestic pigs are easily obtained and inexpensive, because they have been well established as a food source. Therefore, 
Fig. 2. Neighbor-joining phylogenetic trees based on the partial nucleotide sequences of the overlapping open reading frame (ORF) 2/3 (A) and 
ORF2 (B) regions of hepatitis E virus (HEV). The size of the partial sequences of ORF2/3 and ORF2 are 97 bp (nt 5326–5422) and 459 bp 
(nt 5959–6418), respectively (the nucleotide positions correspond to those in the HEV-3 strain Meng). The subtypes of HEV genotype 3 in the 
proposed reference sequences [19] are shown for each strain name. The dendrograms were constructed with a p-distance model using 1,000 
replications. Numbers at the nodes indicate bootstrap supports >70%. The sequences determined in this study are shown in bold with a large font. 
GenBank accession numbers are indicated in parentheses. G1–G7 indicate genotypes 1–7 according to the current proposed classification [18].
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domestic pigs are the most commonly used for animal experiments. For medical research in Japan, pigs of 2 to 3 months of age 
are widely used due to their anatomical size, and many pigs in this age range remain in the animal facilities for a month or two, 
resulting in a large number of 3- to 4-month-old pigs as well. Domestic pigs of these ages are sometimes infected with HEV, and 
become the source of human infection in the swine industries. In the present study, we tried to detect HEV-specific IgG antibodies 
and viral RNA using retrospective plasma samples stored at −80°C to assess HEV infection risk in the experimental animal facility, 
showing that 32.9% (24/73) of samples were sero-positive, although none of the plasma samples was positive for viral RNA. In the 
previous study, serum samples collected from 62 domestic pigs and 15 miniature pigs in 12 Japanese animal facilities were tested 
for anti-HEV antibodies in 2008 [27]. The results showed that 58.1% (36/62) of domestic pigs and 0% (0/15) of miniature pigs 
were positive for anti-HEV IgG antibody. Seroepidemiological findings including those from the present study revealed that the 
domestic pigs used for medical research in Japan were introduced from HEV infection-prevalent farms.
For the above reasons, it is highly desirable to find HEV-free farms to supply pigs for safety experiments. Indeed, Tanaka et al. 
[24] surveyed several commercial farms to find HEV-free farms to supply pigs for safety experiments at Jichi Medical School. 
However, it is practically difficult to supply HEV-free pigs continuously. Because farrow-to-finish farms generally supply slaughter 
houses with pigs approximately 6 months of age, followed by next farrowing, continued surveillance of HEV circulation may 
not always be accomplished on the farm and the HEV-free conditions are not necessarily kept constant. Therefore, when using 
domestic pigs, we should consider the viremia kinetics and virus shedding in feces. In a previous large-scale study designed to test 
2,500 pigs at 25 swine farms in Japan from 2000 to 2002 [21], 58% of serum samples (n=1,448) were positive for anti-HEV IgG, 
of which 7% (37/500), 40% (301/750) and 87% (433/500) were from 2-, 3- and 4-month-old pigs, respectively. HEV RNA was 
detected from serum in 0% (0/180), 15% (113/750) and 13% (24/180) of 2-, 3- and 4-month-old pigs, respectively. Approximately 
90% of pigs of 4–6 months of age are positive for anti-HEV IgG antibody [21]. Another previous study with long-term follow-up 
of virus shedding in naturally infected swine litters with and without maternal antibodies showed that viral RNA was detected 
in feces until 30–110 days of age in both litters [5], and the dates corresponded to the ages of the introduced pigs. During these 
periods, HEV was continuously shed for 63.5 days (range, 50–80 days) in the feces. In the serum, viral RNA was detected until 
60–100 days of age in pigs in the maternal antibody positive-litter and for 40–100 days of age in pigs in the maternal antibody 
negative-litter. Viremia and seroconversion of serum antibodies occurred at 33.5 days (range, 10–60 days) and 32.3 days (range, 
20–50 days) after the onset of HEV shedding in feces, respectively. In the present study, we could not identify the dates of viremia 
because none of the viral RNA was detected in plasma samples. However, 6 of 11 sero-negative samples (54.5%) in 18 sequential 
plasma samples showed seroconversion during the animal experiment period (Fig. 1B, pattern C), indicating that these pigs 
exhibited seroconversion before 32.3 days and shed the virus into the feces. The sero-positive days of pattern C pig plasma were 
14, 54, 49, 212, 63 and 91 days after the animal experiment in pigs no. 5, 6, 11, 13, 14, and 22, respectively. Since the virus was 
continuously shed for 63.5 days into the feces [5], pigs may have been infected not only at the farm but also at the experimental 
animal facility. In our facility, introduced pigs were reared more than 4–5 days during the acclimation period and followed-up in 
individual cages after experiments on the same floor. HEV in pigs is mainly transmitted by a fecal-oral route [11]; therefore, non-
infected pigs might be infected from HEV-contaminated feces and/or water during cage cleaning by facility staff. It is known that 
the prevalence of anti-HEV IgG among pig handlers is higher than that among non-pig handlers worldwide (e.g., China, Moldova, 
Taiwan and U.S.A.) [2, 3, 12, 13]. However, the staff at our facility wear the personal protective equipment (PPE) during cleaning, 
which is not the case for pig handlers at farms. Since viral RNA is detected not only in feces but also in various tissues during the 
viremia period [5, 25], in particular, the medical researchers and trainees should also pay attention to exposure to pig blood during 
experiments and manipulation using these pigs (e.g., needlestick). Indeed, there is a case report in which a surgeon was infected 
with HEV after exposure to 3-month-old pig blood during surgical training [1]. Several reports have documented the transmission 
of HEV through blood transfusions in human cases [9, 14]. The potential risk of HEV infection in experimental animal facilities 
has not been well established; in general, this risk has simply been inferred from the prevalence of HEV infection among pigs 
on farms. Our results indicate that researchers and trainees using domestic pigs as well as staff in the animal facilities are at 
increased potential risk of HEV infection; however, proper PPE use, proper performance of procedures on pigs, and adequate safety 
precautions based on our data will reduce the potential risk of HEV infection.
HEV-3 fragments were amplified in the liver samples from pigs introduced in 2016 and 2017. Two fragments (swHEV-
OKYM/16-2 and swHEV-OKYM/17-1) were closely related subgenotype 3b strains that were indicated to be indigenous to Japan 
[8]. This subgenotype genome was also detected in wild boars in Okayama Prefecture in 2013 [22], indicating that these viruses 
were widely circulating between animals in Okayama Prefecture (i.e., pigs and wild boars). In general, domestic pigs are assigned 
to animal biosafety level 1, and therefore it is necessary to take precautions (e.g., biosafety and quarantine) in experimental animal 
facilities, because some domestic pigs in which HEV is not limited to subgenotype 3b might continue to be introduced.
In the present study, anti-HEV IgG antibodies were detected, but meanwhile no viral RNA was surprisingly detected in stored 
plasma samples collected from the approximately 80–90 days age of domestic pigs although viral RNA was frequently detected 
in these ages of pigs [5, 21]. In any case, the domestic pigs introducing into the facility carry a potential risk of HEV infection. 
To prevent infection during animal experiments using domestic pigs, continuous surveillance of the introduced domestic pigs is 
important and warranted. Because pigs infected with HEV shed viruses into feces for a long period of time [5], it might be also 
essential for detection of swine HEV RNA in the feces.
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